Navigation Links
INTUNIV in Medical News

Shire's INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms

San Francisco, CA May 18, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced new findings on INTUNIV (guanfacine) extended release, a selective alpha-2A-agonist, at a major psychiatric meeting. This randomized placebo controlled trial met i...

Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms

WASHINGTON, May 7 -- Shire plc(LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented today at a major scientific meeting findings from analyses of pivotal trial results of INTUNIV, a selective alpha-2A-agonist. This compound is an investigational once-daily medic...

FDA Approves INTUNIV (guanfacine) for the Treatment of ADHD

Shire announced today that it has received an approvable letter from the US Food and Drug Administration (FDA) for INTUNIV (guanfacine) extended release tablets (previously referred to as SPD503), a nonstimulant selective alpha-2A-receptor agonist, which has been studied in children and adolescent...
INTUNIV in Medical Technology

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

...The FDA did not identify safety concerns regarding intuniv in the Complete Response letter or request new cli...h an important new treatment option." About intuniv intuniv is being studied for the treatment of ADHD in chil...

Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms

...aceutical company, today announced new findings on intuniv (guanfacine) extended release, a selective alpha-2...ry objective, which was to evaluate the effects of intuniv on oppositional symptoms in children aged 6 to 12 ...de additional support for the clinical efficacy of intuniv for treating ADHD in this patient population." ...

Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose

...tivity Disorder (ADHD). The data demonstrated that intuniv showed significant efficacy in reducing ADHD sympt...s for all weight adjusted dose groups treated with intuniv when compared to placebo for all time periods (at ...m the analysis showed that all groups treated with intuniv responded to the medication in a shorter time peri...
INTUNIV in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... Prescription Drug User Fee Act date ("PDUFA") for intuniv was July 27, 2009. Shire has received a Comp...rican countries during 2009 and 2010; - intuniv for the treatment of ADHD in children and adolesce... 158.7 28% 136.4 19% intuniv license payment (36.9) - ...

Shire begins the year with a strong performance

...half of the year we are anticipating the launch of intuniv and the completion of several Phase 2 and Phase 3 ... The Prescription Drug User Fee Act date for intuniv is July 26, 2009 and the launch of intuniv in the US is anticipated for the fourth quar...

Publication of Shire plc's Annual Report 2008

...r 2007 and in the EU via the decentralized procedure, with the Netherlands as the reference member state in December 2007. Reviews are ongoing. intuniv for ADHD in US In June 2007 Shire received an approvable letter from the FDA for INTUNIV. Shire is conducting additional clinical work which is...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...- FIRAZYR (icatibant) for the symptomatic treatment of acute attacks of HAE in certain European and Latin American countries during 2009; - intuniv (guanfacine extended release) for use in the treatment of ADHD in children and adolescents in the US in the second half of 2009; - FO...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

...NIV(TM) - ADHD - On May 8, 2008 Shire announced pivotal trial results for intuniv which is in registration in the US. The data demonstrated that intuniv has significant efficacy in reducing ADHD symptoms for patients taking t...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

...two years: - MEZAVANT in the EU during 2008; - VYVANSE for use in adult patients in the US in Q2 2008; - DAYTRANA in the EU during H1 2009; - intuniv in the US during H2 2009; and - FOSRENOL in the pre-dialysis Chronic Kidney Disease ("CKD") market in the US during 2009. 2008 Financial Outlook ...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

...ada during 2008; - VYVANSE for use in adult patients in the US in Q2 2008 (PDUFA date April 28, 2008); - DAYTRANA in the EU during H1 2009; - intuniv in the US during H2 2009; and - FOSRENOL in the CKD market in the US during 2009. Financial Outlook Shire's business continues to perform strongl...
Other Tags
(Date:7/11/2014)... (PRWEB) July 11, 2014 Volunteers from ... against drug abuse this week with drug education lectures, ... education booklet distribution in cities around the world. , ... U.S. National Institute on Drug Abuse, abuse of alcohol ... annually in crime, lost work, decreased productivity and healthcare. ...
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has been ... Food & Drug Administration’s (FDA) Obstetrics and ... explore ways to mitigate the cancer risks associated ... invasive gynecological surgeries. According to a report published ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The Europe Well ... market in Europe with analysis and revenue forecast. The well ... around $2.4 billion in 2013 to $3.4 billion by 2018, ... Browse through the TOC of the Europe Well Intervention Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/11/2014)... July 11, 2014 Utilizing the Keller ... Dr. William Koenig, has topped a record number of ... has performed over 400 successful procedures without the occurrence ... is well known across the country for his expertise ... record has long been the foundation for numerous studies ...
(Date:7/11/2014)... 2014 (HealthDay News) -- In people with sex addiction, ... to that seen in drug addicts as they consume ... differences in brain activity between patients who have compulsive ... of drug addicts," study author Dr. Valerie Voon, of ... university news release. Voon,s research involved 19 men ...
Breaking Medicine News(10 mins):Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2
(Date:7/11/2014)... 2014 Researchers have pioneered a revolutionary new ... technology, called Virtual Finger, allows scientists to move ... and synapses using the flat surface of their ... imaging studies orders of magnitude more efficient, saving ... across many areas of experimental biology. The software ...
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2Blame it on the astrocytes 2
Other Contents